Capsules

Share

Program Content

Activities

  • HPTN 084: LA CAB for PrEP in Women
    HPTN 084: Long-Acting Injectable Cabotegravir Superior to Daily Oral TDF/FTC for HIV PrEP in Cisgender Women
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 30, 2021

    Expires: January 29, 2022

  • Islatravir for PrEP
    Islatravir Once Monthly for PrEP Demonstrates Favorable Safety/Tolerability and Meets Pharmacokinetic Threshold Target in Blinded Interim Analysis of Phase IIa Trial
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 30, 2021

    Expires: January 29, 2022

  • AMP Trials: bnAb VRC01
    Phase IIb AMP Studies: In Vitro Susceptibility of HIV-1 Isolates to Broadly Neutralizing Antibody VRC01 Predicts HIV Prevention Efficacy in MSM, Transgender Persons, and Cisgender Women
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 03, 2021

    Expires: February 02, 2022

  • TAF Implant for PrEP
    Preclinical Study of Biodegradable Implant Releasing TAF for Prevention of Vaginal SHIV Infection in Pigtailed Macaques
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 03, 2021

    Expires: February 02, 2022

  • CONRAD 138: TFV/LNG Vaginal Ring
    CONRAD 138 (ENRICH): Phase I Trial of Continuous or Interrupted 90-Day TFV/LNG Vaginal Ring in Women Without HIV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 06, 2021

    Expires: February 05, 2022

  • CAB LA in Healthy Adults
    CAB LA Detectable in Plasma, Mucosal Tissue/Fluid Following Single IM Injection in Healthy Adults
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 06, 2021

    Expires: February 05, 2022

  • Event-Driven PrEP in US MSM
    Low Awareness of and Preference for Event-Driven PrEP Among US MSM
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 09, 2021

    Expires: February 08, 2022

  • PrEP-PP
    PrEP-PP Observational Study: PrEP Initiation Among Pregnant and Postpartum Women in South Africa
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 09, 2021

    Expires: February 08, 2022

  • POWER: STIs and PrEP in Adolescent Girls and Young Women
    POWER: Most Diagnosed STIs Asymptomatic Among Adolescent Girls and Young Women Accessing PrEP Services as Part of Integrated Care in Johannesburg, South Africa
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 09, 2021

    Expires: February 08, 2022

  • AMPrEP
    AMPrEP: Transient Decline in PrEP/Condom Use, Sex With Casual Partners Among MSM During COVID-19 Restrictions in the Netherlands
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 10, 2021

    Expires: February 09, 2022

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2018

ProCE Banner

IAS 2021 HIV R4P

ProCE Banner